Strengthening ATMP manufacturing control through real-time metabolic monitoring

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Strengthening ATMP manufacturing control through real-time metabolic monitoring

Improve process consistency and operational control in ATMP manufacturing using continuous glucose and lactate monitoring.

This webinar will show how real-time metabolic data enables earlier detection of process deviations, supports faster optimization, and strengthens decision-making during clinical-stage production.

Through a real-world case study in advanced tissue-engineered therapy manufacturing, attendees will see how continuous monitoring improves process understanding across bioreactor platforms and scales, leading to more precise control during critical steps and reducing labor-intensive sampling and calculations. The session will demonstrate how integrating Process Analytical Technology (PAT) strategies enables automated feeding approaches, reduces reliance on manual sampling, and helps control variability during production.

Attend this webinar to:

Review a case study demonstrating how real-time monitoring enabled early detection and correction of process deviations in an advanced, highly-customized tissue-engineered therapy workflow
Understand how real-time glucose and lactate monitoring improves process performance, strengthens manufacturing consistency, and reduces operational costs
Learn how continuous metabolic monitoring supports process optimization and operational decision-making during clinical-stage ATMP production
Discover how PAT-enabled strategies support automated feeding, reduce manual sampling, and minimize variability across bioreactor platforms and scales

Arvind M. Padma

Lead Scientist in Cell and Gene Therapies at CCRM Nordic

Dr Arvind M. Padma is a biotechnology leader at CCRM Nordic, where he advances cell and gene therapy programs from early innovation through manufacturing and commercialization readiness. He collaborates with startups, academic innovators, and industry partners to strengthen technical strategy, process development, and scalable manufacturing solutions within the ATMP landscape. His work focuses on translating complex scientific breakthroughs into practical, real-world therapeutic applications that accelerate clinical impact. Dr Padma brings deep scientific expertise and a strategic, solutions-driven approach to building and advancing the advanced therapies ecosystem.

Nick Randall

Bioprocessing Product Manager at Repligen

As the Bioprocessing Product Manager at Repligen, Nick Randall is passionate about empowering and supporting customers at the forefront of biotechnology development. He has over ten years of experience as a cross-functional scientist and product manager, specializing in process and product development, operations, manufacturing, automation, and analytical technologies. Nick attempts to leverage this experience to help develop and launch innovative products that solve key issues in the bioprocessing industry.

In 30 Days

You have registered for this webinar